Bronchoscopic lung volume reduction: recent updates

Ramaswamy, Anuradha; Puchalski, Jonathan

doi:10.21037/jtd.2018.02.72

Cited by 11 publications

(14 citation statements)

References 43 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…By the sample size of 26 LVRS patients, this cannot be sufficiently considered. A similar limitation applies to different ELVR approaches (valves, coils, foam, vapor) having a different risk profile (pneumonia, exacerbation and pneumothorax) ( 27 ) and suggesting that their impact on a later LuTX may differ. A possible observer bias must be addressed with regards to the microbiological cultures.…”

Section: Discussionmentioning

confidence: 97%

Lung Volume Reduction Followed by Lung Transplantation in Emphysema—A Multicenter Matched Analysis

Slama

Ceulemans²,

Hedderich

et al. 2022

Transpl Int

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 97%

Lung Volume Reduction Followed by Lung Transplantation in Emphysema—A Multicenter Matched Analysis

Slama

Ceulemans²,

Hedderich

et al. 2022

Transpl Int

View full text Add to dashboard Cite

show abstract

“…40 Patients with upperlobe predominant heterogeneous emphysema are candidates for BTVA, independent of collateral ventilation. 41,42 The procedure consists of applying water vapor heated to 75°C for 3 to 10 seconds utilizing a balloon catheter through a flexible bronchoscope. Before treatment, the balloon is inflated to occlude the proximal end of the bronchus.…”

Section: Bronchoscopic Thermal Vapor Ablationmentioning

confidence: 99%

Bronchoscopic Lung Volume Reduction in Patients with Severe Emphysema

Fernández-Bussy

Labarca

Herth

2018

Semin Respir Crit Care Med

View full text Add to dashboard Cite

Bronchoscopic lung volume reduction (BLVR) is a minimally invasive procedure for patients with symptomatic severe emphysema who may not be candidates for surgical lung volume reduction. BLVR has been shown to improve both functional and clinical outcomes with a relatively low risk of severe complications. Any potential candidate to BLVR should be on optimal pharmacological and nonpharmacological treatment. Radiographic and pulmonary function testing provide key data to help identify potential BLVR candidates. A variety of BLVR techniques have been published with different associated benefits and risks. Current strategies include either blocking procedures such as endobronchial valves and intrabronchial valves or nonblocking procedures such as endobronchial coils and bronchoscopic thermal vapor ablation. The aim of this review is to describe current options of BLVR including their efficacy and safety based on available data.

show abstract

“…Therefore, nonsurgical approaches involving bronchoscopic lung volume reduction (BLVR) have been developed in the last decade. One of these, the BLVR coil procedure, is a treatment option for patients with homogeneous and heterogeneous end-stage emphysema and an FEV 1 of 15-45% [7,8]. This treatment decreases hyperinflation and improves lung function, the quality of life, and exercise capacity.…”

Section: Introductionmentioning

confidence: 99%

Bronchoscopic Lung Volume Reduction Using Coil Therapy: Complications and Management

Gülşen

2020

Advances in Respiratory Medicine

View full text Add to dashboard Cite

Nonsurgical approaches involving bronchoscopic lung volume reduction (BLVR) have been developed in the last decade. One of these, the BLVR coil procedure, is a treatment option for patients with homogeneous and heterogeneous end-stage emphysema and a forced expiratory volume in 1 second (FEV1) of 15–45%. This treatment decreases hyperinflation and improves lung function, the quality of life, and exercise capacity. It is very important to prepare patients for treatment, premedications, anesthesia applications, intubation, post-procedure follow-up and treatments. Further, it has been observed that various complications can develop during and after the procedure. Generally, the observed and reported complications are chronic obstructive pulmonary disease (COPD) exacerbation, chest pain, mild bleeding, pneumonia, pneumothorax, and respiratory failure. Rarely, aspergillus cavitation (coil-related aspergilloma), bronchopleural fistula and penetration into the pleural space, bronchiectasis, coil-associated inflammatory response and opacities, and hiccups are observed. Common complications are usually mild or moderate, while the rare ones can be life-threatening (except hiccup), so early diagnosis and treatment are necessary. However, patients treated with BLVR have lower mortality rates than untreated patients with similar morbidity. Based on the findings of this review, we can estimate that premedication one day before and just before the procedure may reduce potential complications. Some medical centers apply and recommend 30-day macrolide treatment after the procedure. New generation supraglottic devices may be preferred to avoid complications due to endotracheal intubation. Moreover, further research is needed to identify risk factors, prevent potential complications, and a common consensus is required for routine preventive treatment.

show abstract

Bronchoscopic lung volume reduction: recent updates

Cited by 11 publications

References 43 publications

Lung Volume Reduction Followed by Lung Transplantation in Emphysema—A Multicenter Matched Analysis

Lung Volume Reduction Followed by Lung Transplantation in Emphysema—A Multicenter Matched Analysis

Bronchoscopic Lung Volume Reduction in Patients with Severe Emphysema

Bronchoscopic Lung Volume Reduction Using Coil Therapy: Complications and Management

Contact Info

Product

Resources

About